litlas
ログインアカウント作成

Rolf A. Stahel

1985–2025 年に発表

111
論文数
22,230
被引用数
83
h 指数
108
i10 指数

被引用数

Rolf A. Stahel の年別被引用数1971 年: 被引用 3 件1987 年: 被引用 3 件1988 年: 被引用 3 件1989 年: 被引用 6 件1990 年: 被引用 1 件1991 年: 被引用 6 件1992 年: 被引用 7 件1993 年: 被引用 4 件1994 年: 被引用 3 件1995 年: 被引用 9 件1996 年: 被引用 6 件1997 年: 被引用 10 件1998 年: 被引用 15 件1999 年: 被引用 20 件2000 年: 被引用 22 件2001 年: 被引用 38 件2002 年: 被引用 57 件2003 年: 被引用 77 件2004 年: 被引用 77 件2005 年: 被引用 70 件2006 年: 被引用 54 件2007 年: 被引用 117 件2008 年: 被引用 145 件2009 年: 被引用 140 件2010 年: 被引用 141 件2011 年: 被引用 131 件2012 年: 被引用 138 件2013 年: 被引用 127 件2014 年: 被引用 117 件2015 年: 被引用 146 件2016 年: 被引用 148 件2017 年: 被引用 134 件2018 年: 被引用 133 件2019 年: 被引用 492 件2020 年: 被引用 632 件2021 年: 被引用 596 件2022 年: 被引用 473 件2023 年: 被引用 403 件2024 年: 被引用 678 件2025 年: 被引用 353 件2026 年: 被引用 8 件1972〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,867 件、この内訳の 19.4%中国: 引用元論文 974 件、この内訳の 10.1%イタリア: 引用元論文 656 件、この内訳の 6.8%ドイツ: 引用元論文 586 件、この内訳の 6.1%イギリス: 引用元論文 548 件、この内訳の 5.7%フランス: 引用元論文 476 件、この内訳の 5%スイス: 引用元論文 394 件、この内訳の 4.1%スペイン: 引用元論文 361 件、この内訳の 3.8%日本: 引用元論文 340 件、この内訳の 3.5%カナダ: 引用元論文 336 件、この内訳の 3.5%オランダ: 引用元論文 332 件、この内訳の 3.5%オーストラリア: 引用元論文 240 件、この内訳の 2.5%
0%19.4%その他 26%

機関

分野

  • Medicine72.7%
  • Biochemistry, Genetics and Molecular Biology21%
  • Immunology and Microbiology3.4%
  • Engineering0.6%
  • Materials Science0.5%
  • Computer Science0.4%
  • その他1.4%

トピック

  • Lung Cancer Treatments and Mutations7.5%
  • Cancer Immunotherapy and Biomarkers5.5%
  • Lung Cancer Diagnosis and Treatment5.3%
  • Lung Cancer Research Studies4.5%
  • Lymphoma Diagnosis and Treatment3.6%
  • Occupational and environmental lung diseases2.9%
  • その他70.7%

共著者

全論文

検索で開く
  1. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial

    著者: Mary O’Brien, Luis Paz‐Ares, Sandrine Marréaud, Urania Dafni, Kersti Oselin, Libor Havel, Emilio Esteban, Dolores Isla, Alex Martínez‐Martí, Martin Faehling, Masahiro Tsuboi, Jong Seok Lee, Kazuhiko Nakagawa, Jing Yang, Ayman Samkari, Steven M. Keller, Murielle Mauer, Nitish Jha, Rolf A. Stahel, Benjamin Besse, Solange Peters - The Lancet Oncology 2022 被引用: 744

  2. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

    著者: Émilie Le Rhun, Matthias Gückenberger, Marion Smits, Reinhard Dummer, Thomas Bachelot, Felix Sahm, Norbert Galldiks, Evandro de Azambuja, Anna S. Berghoff, Philippe Métellus, Solange Peters, Yuna Hong, Frank Winkler, Dirk Schadendorf, Martin J. van den Bent, Joan Seoane, Rolf A. Stahel, Giuseppe Minniti, Pieter Wesseling, Michael Weller, Matthias Preusser - Annals of Oncology 2021 被引用: 579

  3. ESMO Guidance for Reporting Oncology real-World evidence (GROW)

    著者: Luís Castelo-Branco, Anna Pellat, Diogo Martins-Branco, Antonios Valachis, Jeroen W. G. Derksen, Karijn P.M. Suijkerbuijk, Urania Dafni, Tereza Dellaporta, Arndt Vogel, Arsela Prelaj, Rolf H. H. Groenwold, Henrique Martins, Rolf A. Stahel, Judith M. Bliss, Jakob Nikolas Kather, Nuria Ribelles, Francesco Perrone, Peter S Hall, Rodrigo Dienstmann, Christopher M. Booth, George Pentheroudakis, Suzette Delaloge, Miriam Koopman - Annals of Oncology 2023 被引用: 210

  4. Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

    著者: Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jérusalem, Rupert Bartsch, Manuela Rabaglio, Roswitha Kammler, Rudolf Maibach, Mark J. Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M. Regan, Fabrice André, Debora Fumagalli, Richard D. Gelber, Theodora Goulioti, Anita Hiltbrunner, Rita L. Hui, Heidi Roschitzki, Barbara Ruepp, Frances M. Boyle, Rolf A. Stahel, Stefan Aebi, Alan S. Coates, Aron Goldhirsch, Per Karlsson, Ingrid Kössler, Stamatina Fournarakou, Adriana Gasca, Rita Pfister, Sabrina Ribeli-Hofmann, Magdelena Weber, Daniela Celotto, Carmen Comune, M. Frapolli, Magdalena Sánchez-Hohl, Hui Huang, Caitlin Mahoney, Karen N. Price, Karolyn Scott, Holly Shaw, Susan M. Fischer, Mónica Greco, Colleen King, Stefania Andrighetto, Martine Piccart, Heather E. Findlay, Michelle Jenkins, Vassiliki Karantza, Jaime Mejia, Patrick Schneier - The Lancet Oncology 2019 被引用: 477

  5. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

    著者: Viviana Galimberti, Bernard F. Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Žgajnar, Mario Taffurelli, David R. G. Littlejohn, Michael Knauer, Carlo Tondini, Angelo Di Leo, Marco Colleoni, Meredith M. Regan, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Frances M. Boyle, Guy Jérusalem, Rolf A. Stahel, Stefan Aebi, Michael J. Green, Per Karlsson, Ingrid Kössler, István Láng, Anita Hiltbrunner, Jürg Bernhard, Stamatina Fournarakou, Roswitha Kammler, Rudolf Maibach, Manuela Rabaglio, Karin Ribi, Heidi Roschitzki, Susanne Roux, Barbara Ruepp, Caitlin Mahoney, Karen N. Price, L. J. Blacher, Tara Scolese, Karolyn Scott, Sandra Lippert, Theresa Julia Zielinski, Mauro G. Mastropasqua, Stefania Andrighetto, Patrizia Dell’Orto, Giuseppe Renne, Giancarlo Pruneri, Silvia Dellapasqua, Monica Iorfida, Giuseppe Cancello, Emilia Montagna, Anna Cardillo, G. Peruzzotti, R. Ghisini, Alberto Luini, Umberto Veronesi, Mattia Intra, Oreste ­Gentilini, Stefano Zurrida, Giuseppe Curigliano, Franco Nolè, Roberto Orecchia, Marisa Cristina Leonardi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Diana Crivellari, Sandro Morassut, Mario Mileto, Erica Piccoli, Andreas Veronesi, Marisa Donatella Magri, Angelo Buonadonna, Ezio Candiani, Antonino Carbone, Tiziana Perin, Rachele Volpe, Mario Roncadin, Mauro Arcicasa, Francesco Coran, Manuela Lagrassa, A. Recalcati, Maria Emanuela Limonta, Paolo Tricomi, P. Fenaroli, Elisabetta Candiago, Laura Cattaneo, Alberto Gianatti, Donatella Santini, Sylvie Maweja, Philippe Delvenne, Andrée Rorive, Joëlle Collignon, Jean-Rémi Garbay, Marie‐Christine Mathieu, Hanne Galatius, J Hoffmann, Peer Schousen ほか 102 名 - The Lancet Oncology 2018 被引用: 565

  6. Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

    著者: Solange Peters, Rolf A. Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M. Kowalski, Christina S. Baik, Dolores Isla, Javier de Castro, Pilar Garrido, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H. Lam, Michael W. Lu, Thomas E. Stinchcombe - Clinical Cancer Research 2018 被引用: 230

  7. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

    著者: Michael Pfreundschuh, Lorenz Trümper, Anders Österborg, Ruth Pettengell, Marek Trněný, Kevin Imrie, Dávid Ma, Devinder Gill, Jan Walewski, Pier Luigi Zinzani, Rolf A. Stahel, Stein Kvaløy, Ofer Shpilberg, Ulrich Jaeger, Mads Hansen, Tuula Lehtinen, Armando López‐Guillermo, Claudia Corrado, Adriana Scheliga, Nöel Milpied, Myriam Mendila, Michelle Rashford, Evelyn Kuhnt, Markus Loeffler - The Lancet Oncology 2006 被引用: 2,085

  8. Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)

    著者: Solange Peters, Enriqueta Felip, Urania Dafni, Amanda Tufman, Matthias Gückenberger, Ruth Álvarez, Ernest Nadal, Annemarie Becker‐Commissaris, Hansjörg Vees, Miklos Pless, Alex Martínez‐Martí, Maarten Lambrecht, Nicolaus Andratschke, Zoi Tsourti, Anne‐Christine Piguet, Heidi Roschitzki‐Voser, A. Gasca-Ruchti, Johan Vansteenkiste, Rolf A. Stahel, Dirk De Ruysscher - Journal of Thoracic Oncology 2020 被引用: 136

  9. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

    著者: Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, Anders Österborg, Marek Trněný, Lois E. Shepherd, Devinder Gill, Jan Walewski, Ruth Pettengell, Ulrich Jaeger, Pier Luigi Zinzani, Ofer Shpilberg, Stein Kvaløy, Peter de Nully Brown, Rolf A. Stahel, Nöel Milpied, Armando López‐Guillermo, Viola Poeschel, Sandra Graß, Markus Loeffler, Niels Murawski - The Lancet Oncology 2011 被引用: 811

  10. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

    著者: Stefanie Hiltbrunner, Christian Britschgi, Petra Schuberth, Lorenz Bankel, Thi Dan Linh Nguyen‐Kim, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Hans Bachmann, Annett Tabor, Petra Schröder, Alexander Knuth, Christian Münz, Rolf A. Stahel, Onur Boyman, Christoph Renner, Ulf Petrausch, Alessandra Curioni‐Fontecedro - Annals of Oncology 2020 被引用: 88

  11. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

    著者: Petra Schuberth, Christian Hagedorn, Shawn M. Jensen, Pratiksha Gulati, Maries van den Broek, Axel Mischo, Alex Soltermann, Astrid Jüngel, Osiris Marroquin Belaunzaran, Rolf A. Stahel, Christoph Renner, Ulf Petrausch - Journal of Translational Medicine 2013 被引用: 205

  12. A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

    著者: Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni, R. Shah, Mary O’Brien, A. Pope, P.M. Fisher, James Spicer, A. Roy, David Gilligan, Oliver Gautschi, Ernest Nadal, Wolf-Dieter Janthur, Rafael López Castro, Rosario García Campelo, Sylvie Rusakiewicz, Igor Letovanec, Varvara Polydoropoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, A. Gasca-Ruchti, Solange Peters, Rolf A. Stahel - Annals of Oncology 2020 被引用: 273

  13. A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

    著者: Ross A. Soo, Ji‐Youn Han, Urania Dafni, Byoung Chul Cho, Chong Ming Yeo, Ernest Nadal, Enric Carcereny, J. de Castro, María Ángeles Sala, Reyes Bernabé, Linda Coate, M. Provencio Pulla, Rosario García Campelo, Sinéad Cuffe, Sayed M.S. Hashemi, Martin Früh, Bartomeu Massutí, José García-Sánchez, Manuel Dómine, Margarita Majem, J.M. Sánchez-Torres, Christian Britschgi, Miklos Pless, Georgia Dimopoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, Rafael Rosell, Rolf A. Stahel, Solange Peters, Rolf A. Stahel, Solange Peters, Ross A. Soo, Ji‐Youn Han, Martin Früh, Mariano Provencio, Linda Coate, Urania Dafni, Anita Hiltbrunner, Barbara Ruepp, Heidi Roschitzki‐Voser, Anita Hiltbrunner, Adriana Gasca-Ruchti, Nino Giacomelli, Rosita Kammler, Nesa Marti, Lionel Nobs, Mariana Pardo-Contreras, Rita Pfister, Anne‐Christine Piguet, Sabrina Ribeli-Hofmann, Virginia Rodriguez Martinez, Heidi Roschitzki‐Voser, Susanne Roux, Barbara Ruepp, Magdalena Sánchez-Hohl, Mirjam Schneider, Robin Schweri, Sandra Troesch, Isabel Zigomo, Urania Dafni, Zoi Tsourti, Panagiota Zygoura, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Maria Fernandez, Eva Pereira, Carolina Simona, Lisa Tucker, Jillian Burnes, Aisling Barrett, Meghan McGrillen, Catherine Berset, Christine Biaggi, M. Reist, Priska Rentsch, Linda Coate, Sinéad Cuffe, Sayed M.S. Hashemi, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Bernabé Reyes, Mariano Provencio Pulla, Rosario García Campelo, Bartomeu Massutí, José López García, Manuel Dómine, Margarita Majem, José Miguel Sánchez, Martin Früh, Christian Britschgi, Miklos Pless, Solange Peters, Ross A. Soo, Chong Ming Yeo, Ji‐Youn Han, Byoung Chul Cho - Annals of Oncology 2021 被引用: 116

  14. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

    著者: Solange Peters, Jean-Louis Pujol, Urania Dafni, Manuel Dómine, Sanjay Popat, Martin Reck, J. Andrade, A. Becker, Denis Moro‐Sibilot, Alessandra Curioni‐Fontecedro, Olivier Molinier, Kristiaan Nackaerts, A. Insa Mollá, R. Gervais, Guillermo López-Vivanco, J. Madelaine, Julien Mazières, Martin Faehling, Frank Griesinger, Margarita Majem, J.L. González-Larriba, M. Provencio Pulla, Katerina Vervita, Heidi Roschitzki‐Voser, Barbara Ruepp, Paul Mitchell, Rolf A. Stahel, C. Le Péchoux, Dirk De Ruysscher, Rolf A. Stahel, Anita Hiltbrunner, Mariana Pardo-Contreras, A. Gasca-Ruchti, Nino Giacomelli, Roswitha Kammler, Nesa Marti, Rita Pfister, Anne‐Christine Piguet, Susanne Roux, Sandra Troesch, M. Schneider, Robin Schweri, Isabel Zigomo, Zoi Tsourti, Panagiota Zygoura, S. Tsouprou, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Franck Morin, Elodie Amour, G. Mariaule, N. Archirel, María Dolores Arnaiz Fernández, E. Pereira, M. Fernandez, K. Lopez, Ainhoa Hernández, Sarah Chinchen, H. Jurkovic, Alan S. Livingstone, Jerry W. Mitchell, Macie B. Walker, Paul Mitchell, S. Ng, Christopher Steer, Karen Briscoe, Amina Saqib, Ehtesham Abdi, Baerin Houghton, Kenneth J. O’Byrne, B.R. Chittajallu, Brett Hughes, A. Black, Kristiaan Nackaerts, Henrica M.J. Werner, R. Gervais, Gérard Zalcman, F. Vaylet, P. Merle, I. Monnet, Denis Moro‐Sibilot, Olivier Molinier, Nicolas Girard, P.-J. Souquet, Fabrice Barlési, D. Debieuvre, Hélène Senellart, M. Poudenx, A. Dixmier, Damien Pouessel, Jacques Cadranel, H. Léna, Élisabeth Quoix, S. Friard, Clarisse Audigier-Valette, Julien Mazières, Éric Pichon, Martin Faehling ほか 20 名 - Annals of Oncology 2021 被引用: 114

  15. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

    著者: Miklos Pless, Roger Stupp, Hans-Beat Ris, Rolf A. Stahel, Walter Weder, Sandra Thierstein, Marie-Aline Gérard, Alexandros Xyrafas, Martin Früh, Richard Cathomas, Alfred Zippelius, Arnaud Roth, Milorad Bijelović, Adrian F. Ochsenbein, Urs R. Meier, Christoph Mamot, Daniel Rauch, Oliver Gautschi, Daniel Betticher, René-Olivier Mirimanoff, Solange Peters - The Lancet 2015 被引用: 390

  16. Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

    著者: Rafał Dziadziuszko, Egbert F. Smit, Urania Dafni, Juergen Wolf, Bartosz Wasąg, Wojciech Biernat, Stephen P. Finn, Roswitha Kammler, Zoi Tsourti, Manuela Rabaglio, Barbara Ruepp, Heidi Roschitzki‐Voser, Rolf A. Stahel, Enriqueta Felip, Solange Peters - Journal of Thoracic Oncology 2019 被引用: 155

  17. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    著者: Johan Vansteenkiste, Lucio Crinò, Christophe Dooms, Jean-Yves Douillard, Corinne Faivre‐Finn, Eric Lim, Gaetano Rocco, Suresh Senan, Paul Van Schil, Paolo Veronesi, Rolf A. Stahel, Solange Peters, Enriqueta Felip, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Paolo Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, W. Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2014 被引用: 495

  18. PD-1 blockade in advanced NSCLC: A focus on pembrolizumab

    著者: Solange Peters, Keith M. Kerr, Rolf A. Stahel - Cancer Treatment Reviews 2017 被引用: 169

  19. Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

    著者: Solange Peters, Enriqueta Felip, Urania Dafni, Claus Belka, Matthias Gückenberger, Antonio Irigoyen López, Ernest Nadal, A. Becker, Hansjörg Vees, Miklos Pless, Alex Martínez‐Martí, Amanda Tufman, Maarten Lambrecht, Nicolaus Andratschke, Anne‐Christine Piguet, Marie Kassapian, Heidi Roschitzki‐Voser, Manuela Rabaglio, Rolf A. Stahel, Johan Vansteenkiste, Dirk De Ruysscher - Lung Cancer 2019 被引用: 161

  20. A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells

    著者: A. Curioni, Christian Britschgi, Stefanie Hiltbrunner, Lorenz Bankel, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Alexander Knuth, Christian Münz, C. Renner, Rolf A. Stahel, Ulf Petrausch - Annals of Oncology 2019 被引用: 53

  21. Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data

    著者: M. Pérol, Enriqueta Felip, Urania Dafni, Letizia Polito, Navdeep Pal, Zoi Tsourti, Thanh G.N. Ton, David M. Merritt, S. Morris, Rolf A. Stahel, Solange Peters - Annals of Oncology 2022 被引用: 104

  22. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    著者: Wilfried Eberhardt, Dirk De Ruysscher, Walter Weder, C. Le Péchoux, Paul De Leyn, H. Hoffmann, Virginie Westeel, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2015 被引用: 398

  23. Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

    著者: Ulf Petrausch, Petra Schuberth, Christian Hagedorn, Alex Soltermann, Sandra Tomaszek, Rolf A. Stahel, Walter Weder, Christoph Renner - BMC Cancer 2012 被引用: 90

  24. Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project

    著者: Stephen P. Finn, Alfredo Addeo, Urania Dafni, Erik Thunnissen, Lukas Bubendorf, Line Bille Madsen, Wojciech Biernat, Eric Verbeken, Javier Hernández‐Losa, Antonio Marchetti, Richard Cheney, Arne Warth, Ernst‐Jan M. Speel, Anne Marie Quinn, Kim Monkhorst, Eloísa Jantus‐Lewintre, Verena Tischler, Nesa Marti, Georgia Dimopoulou, Miguel Ángel Molina‐Vila, Roswitha Kammler, Keith M. Kerr, Solange Peters, Rolf A. Stahel - Journal of Thoracic Oncology 2021 被引用: 64